TET2 c.2602T>C ;(p.F868L)

Variant ID: 4-106157701-T-C

NM_001127208.2(TET2):c.2602T>C;(p.F868L)

This variant was identified in 16 publications

View GRCh38 version.




Publications:


Comprehensive germline and somatic genomic profiles of Chinese patients with biliary tract cancer.

Frontiers In Oncology
Yu, Haipeng H; Xu, Yan Y; Gao, Wei W; Li, Mei M; He, Ji'an J; Deng, Xiaoqian X; Xing, Wenge W
Publication Date: 2022

Variant appearance in text: TET2: F868L
PubMed Link: 36072793
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



Myelodysplastic syndromes are multiclonal diseases derived from hematopoietic stem and progenitor cells.

Experimental Hematology & Oncology
Luo, Bingqing B; Dong, Fang F; Qin, Tiejun T; Zhang, Qingyun Q; Bai, Haitao H; Wang, Jinhong J; Jia, Yujiao Y; Ma, Shihui S; Jiang, Erlie E; Cheng, Tao T; Xiao, Zhijian Z; Ema, Hideo H
Publication Date: 2022-05-16

Variant appearance in text: TET2: F868L
PubMed Link: 35578364
Variant Present in the following documents:
  • 40164_2022_280_MOESM2_ESM.pdf
View BVdb publication page



Targeted Therapy of Papillary Thyroid Cancer: A Comprehensive Genomic Analysis.

Frontiers In Endocrinology
Hescheler, Daniel A DA; Riemann, Burkhard B; Hartmann, Milan J M MJM; Michel, Maximilian M; Faust, Michael M; Bruns, Christiane J CJ; Alakus, Hakan H; Chiapponi, Costanza C
Publication Date: 2021

Variant appearance in text: TET2: F868L
PubMed Link: 34630336
Variant Present in the following documents:
  • Table_1.xlsx, sheet 2
View BVdb publication page



Clinical and molecular features of Epstein-Barr virus-positive diffuse large B-cell lymphoma: Results in a multi-center trial.

Clinical And Translational Medicine
Zhao, Chen Xing CX; Wen, Jing Jing JJ; Fu, Di D; Xu, Peng Peng PP; Cheng, Shu S; Wang, Li L; Wang, Chao Fu CF; Fei, Xiao Chun XC; Wang, Xin X; Zhou, Jian Feng JF; Su, Li Ping LP; Chen, Zhuo Wen ZW; Chen, Jie Ping JP; Fang, Mei Yun MY; Liu, Ting T; Song, Yong Ping YP; Yu, Kang K; Li, Yan Y; Gu, Jian J; Hou, Ming M; Zhao, Wei Li WL; da Hu, Jian J
Publication Date: 2021-09

Variant appearance in text: TET2: F868L
PubMed Link: 34586746
Variant Present in the following documents:
  • CTM2-11-e539-s009.pdf
View BVdb publication page



HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia.

Nature Communications
Zhu, Ganqian G; Luo, Huacheng H; Feng, Yang Y; Guryanova, Olga A OA; Xu, Jianfeng J; Chen, Shi S; Lai, Qian Q; Sharma, Arati A; Xu, Bing B; Zhao, Zhigang Z; Feng, Ru R; Ni, Hongyu H; Claxton, David D; Guo, Ying Y; Mesa, Ruben A RA; Qiu, Yi Y; Yang, Feng-Chun FC; Li, Wei W; Nimer, Stephen D SD; Huang, Suming S; Xu, Mingjiang M
Publication Date: 2021-03-29

Variant appearance in text: TET2: F868L
PubMed Link: 33782403
Variant Present in the following documents:
  • 41467_2021_22095_MOESM1_ESM.pdf
View BVdb publication page



Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome.

Frontiers In Oncology
Fang, Ying Y; Guo, Juan J; Wu, Dong D; Wu, Ling-Yun LY; Song, Lu-Xi LX; Zhang, Zheng Z; Zhao, You-Shan YS; Chang, Chun-Kang CK
Publication Date: 2020

Variant appearance in text: TET2: F868L
PubMed Link: 33520721
Variant Present in the following documents:
  • Table_2.xlsx, sheet 1
View BVdb publication page



Establishment of a High-risk MDS/AML Cell Line YCU-AML1 and its Xenograft Model Harboring t(3;3) and Monosomy 7.

Hemasphere
Kunimoto, Hiroyoshi H; Fukuchi, Yumi Y; Murakami, Koichi K; Ikeda, Junji J; Teranaka, Hiroshi H; Kato, Ikuma I; Miyazaki, Takuya T; Enaka, Makiko M; Mitsuhashi, Takayuki T; Yamazaki, Etsuko E; Kameyama, Kaori K; Murata, Mitsuru M; Okamoto, Shinichiro S; Nakajima, Hideaki H
Publication Date: 2020-10

Variant appearance in text: TET2: F868L
PubMed Link: 33163905
Variant Present in the following documents:
  • Main text
View BVdb publication page



TET2 Single Nucleotide Polymorphism in Myeloid Neoplasms Among Egyptian Patients.

Indian Journal Of Hematology & Blood Transfusion : An Official Journal Of Indian Society Of Hematology And Blood Transfusion
Dammag, Enas A EA; Hamed, Nahla A M NAM; Elhalawani, Nabil A NA; Kassem, Heba S HS; Ayad, Mona W MW
Publication Date: 2020-01

Variant appearance in text: TET2: F868L
PubMed Link: 32158090
Variant Present in the following documents:
  • Main text
View BVdb publication page



DNA methylation loss promotes immune evasion of tumours with high mutation and copy number load.

Nature Communications
Jung, Hyunchul H; Kim, Hong Sook HS; Kim, Jeong Yeon JY; Sun, Jong-Mu JM; Ahn, Jin Seok JS; Ahn, Myung-Ju MJ; Park, Keunchil K; Esteller, Manel M; Lee, Se-Hoon SH; Choi, Jung Kyoon JK
Publication Date: 2019-09-19

Variant appearance in text: TET2: F868L
PubMed Link: 31537801
Variant Present in the following documents:
  • 41467_2019_12159_MOESM8_ESM.xlsx, sheet 1
View BVdb publication page



Mutational spectrum and associations with clinical features in patients with acute myeloid leukaemia based on next‑generation sequencing.

Molecular Medicine Reports
Li, Ying Y; Lv, Xiao X; Ge, Xueling X; Yuan, Dai D; Ding, Mei M; Zhen, Changqing C; Zhao, Wenbo W; Liu, Xin X; Wang, Xianghua X; Xu, Hongzhi H; Li, Ying Y; Wang, Xin X
Publication Date: 2019-05

Variant appearance in text: TET2: F868L
PubMed Link: 30942411
Variant Present in the following documents:
  • Main text
  • mmr-19-05-4147.pdf
View BVdb publication page



[Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia].

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
Qu, S Q SQ; Qin, T J TJ; Xu, Z F ZF; Zhang, Y Y; Jia, Y J YJ; Ai, X F XF; Zhang, H L HL; Fang, L W LW; Hu, N B NB; Pan, L J LJ; Li, B B; Liu, J Q JQ; Ru, K K; Xiao, Z J ZJ
Publication Date: 2018-06-14

Variant appearance in text: TET2: F868L
PubMed Link: 30032569
Variant Present in the following documents:
  • Main text
  • cjh-39-06-501.pdf
View BVdb publication page



Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing.

Oncotarget
Nakagaki, Takafumi T; Tamura, Miyuki M; Kobashi, Kenta K; Koyama, Ryota R; Fukushima, Hisayo H; Ohashi, Tomoko T; Idogawa, Masashi M; Ogi, Kazuhiro K; Hiratsuka, Hiroyoshi H; Tokino, Takashi T; Sasaki, Yasushi Y
Publication Date: 2017-08-29

Variant appearance in text: TET2: Phe868Leu
PubMed Link: 28938622
Variant Present in the following documents:
  • oncotarget-08-59113-s005.xlsx, sheet 1
View BVdb publication page



[How I treat myelodysplastic symdromes].

Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi
Xiao, Z J ZJ
Publication Date: 2017-04-14

Variant appearance in text: TET2: F868L
PubMed Link: 28468085
Variant Present in the following documents:
  • cjh-38-04-268.pdf
View BVdb publication page



Whole-genome sequencing of the world's oldest people.

Plos One
Gierman, Hinco J HJ; Fortney, Kristen K; Roach, Jared C JC; Coles, Natalie S NS; Li, Hong H; Glusman, Gustavo G; Markov, Glenn J GJ; Smith, Justin D JD; Hood, Leroy L; Coles, L Stephen LS; Kim, Stuart K SK
Publication Date: 2014

Variant appearance in text: TET2: F868L
PubMed Link: 25390934
Variant Present in the following documents:
  • pone.0112430.s004.xlsx, sheet 1
View BVdb publication page



Clonal leukemic evolution in myelodysplastic syndromes with TET2 and IDH1/2 mutations.

Haematologica
Lin, Tung-Liang TL; Nagata, Yasunobu Y; Kao, Hsiao-Wen HW; Sanada, Masashi M; Okuno, Yusuke Y; Huang, Chein-Fuang CF; Liang, Der-Cherng DC; Kuo, Ming-Chung MC; Lai, Chang-Liang CL; Lee, En-Hui EH; Shih, Yu-Shu YS; Tanaka, Hiroko H; Shiraishi, Yuichi Y; Chiba, Kenichi K; Lin, Tung-Huei TH; Wu, Jin-Hou JH; Miyano, Satoru S; Ogawa, Seishi S; Shih, Lee-Yung LY
Publication Date: 2014-01

Variant appearance in text: TET2: F868L
PubMed Link: 23996483
Variant Present in the following documents:
  • Main text
View BVdb publication page